Literature DB >> 8380097

Inversion of a chicken ets-1 proto-oncogene segment in avian leukemia virus E26.

J A Lautenberger1, T S Papas.   

Abstract

The segment of the avian leukemia virus E26 genome near the termination of the p135gag-myb-ets open reading frame contains an inversion of the chicken ets-1 sequence. The inversion contains at least 41 bp and may be as large as 46 bp. This results in the replacement of 13 amino acids of chicken ets-1, with 16 amino acids derived from reverse complement of the normal ets-1 coding strand or read-through into E26 env sequences. At least 13 of these codons are specified by the inverted ets sequences. This represents the first reported occurrence of inverted oncogene sequences in a natural retrovirus. The inverted ets sequences are immediately followed by sequences homologous to the Rous sarcoma virus Prague B env gene. Since the E26 env sequence is more closely related to subgroup B avian retroviruses than to avian retroviruses from subgroups A, C, D, or E, the progenitor of E26 was a virus belonging to avian retrovirus subgroup B.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380097      PMCID: PMC237405     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.

Authors:  J Hagman; R Grosschedl
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  The avian retrovirus env gene family: molecular analysis of host range and antigenic variants.

Authors:  C A Bova; J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Cloning and expression of chicken p54c-ets cDNAs: the first p54c-ets coding exon is located into the 40.0 kbp genomic domain unrelated to v-ets.

Authors:  M Duterque-Coquillaud; D Leprince; A Flourens; C Henry; J Ghysdael; B Debuire; D Stehelin
Journal:  Oncogene Res       Date:  1988-05

4.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 5.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Nucleotide sequence of Rous sarcoma virus.

Authors:  D E Schwartz; R Tizard; W Gilbert
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

7.  Molecular basis of host range variation in avian retroviruses.

Authors:  A J Dorner; J P Stoye; J M Coffin
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  env genes of avian retroviruses: nucleotide sequence and molecular recombinants define host range determinants.

Authors:  C A Bova; J P Manfredi; R Swanstrom
Journal:  Virology       Date:  1986-07-30       Impact factor: 3.616

9.  Molecular organization of the chicken ets locus.

Authors:  D K Watson; M J McWilliams; T S Papas
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

10.  Sites of recombination between the transforming gene of avian myeloblastosis virus and its helper virus.

Authors:  N C Kan; M A Baluda; T S Papas
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

View more
  3 in total

1.  Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.

Authors:  L W Donaldson; J M Petersen; B J Graves; L P McIntosh
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

2.  A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.

Authors:  N Soudant; O Albagli; P Dhordain; A Flourens; D Stéhelin; D Leprince
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

3.  In vivo cooperation of two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, leads to transformation and immortalization of chicken myelomonocytic cells.

Authors:  G Adelmant; B Quatannens; C Lagrou; N Wernert; G Torpier; S Saule; D Stehelin; V Laudet
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.